Kelly John Alexander sold DTIL
November 3, 2025 · Form 4 insider transaction
Kelly John Alexander sold 1,303 shares of Precision BioSciences, Inc. at $6.49 per share, a transaction worth $8.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,303
Price
$6.49
Total value
$8.5K
InsiderKelly John Alexander
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 3, 2025
Filing dateNovember 4, 2025
Shares owned after77,298
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.